Showing results (991-1000 of 1,023) with videos related to

Sort By:
Pageof 103
Contemporary Clinical Trials|March 20, 2019
Design and recruitment of the randomized order safety trial evaluating resident-physician schedules (ROSTERS) studyTerri Blackwell, Dana R Kriesel, Eric Vittinghoff, et al.
Plos Medicine|May 6, 2024
Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR)Ahmed M Arzika, Amza Abdou, Ramatou Maliki, et al.
Emerging Infectious Diseases|April 19, 2017
Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USAJohn R Papp, A Jeanine Abrams, Evelyn Nash, et al.
BMC Public Health|April 30, 2021
Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)Kieran S O'Brien, Ahmed M Arzika, Abdou Amza, et al.
Journal of Mammary Gland Biology and Neoplasia|September 30, 2016
Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to MetastasisRachel Eyre, Denis G Alférez, Kath Spence, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2021
Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized TrialAhmed M Arzika, Ramatou Maliki, Amza Abdou, et al.
Leukemia|February 6, 2016
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibitionS Köhrer, O Havranek, F Seyfried, et al.
Maternal & Child Nutrition|September 27, 2022
Anthropometric deficits and the associated risk of death by age and sex in children aged 6-59 months: A meta-analysisSusan Thurstans, Stephanie V Wrottesley, Bridget Fenn, et al.
Blood Cancer Journal|September 24, 2016
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaN Gökbuget, M Kelsh, V Chia, et al.
JAMA Network Open|July 10, 2025
Spillover of Azithromycin Mass Drug Administration and Child Survival: A Secondary Analysis of a Cluster-Randomized Clinical TrialAhmed M Arzika, Abdou Amza, Ramatou Maliki, et al.
Pageof 103